Open AccessSerum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus
Author(s) -
Georgios Renieris,
Konstantina Katrini,
Christina Damoulari,
Karolina Akinosoglou,
Christos Psarrakis,
Magdalini Kyriakopoulou,
George Dimοpoulos,
Malvina Lada,
Panagiotis Koufargyris,
Evangelos J. GiamarellosBourboulis
Publication year - 2020
Publication title -
shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/shk.0000000000001562
Subject(s) - procalcitonin , medicine , pneumonia , gastroenterology , covid-19 , c reactive protein , sepsis , inflammation , disease , infectious disease (medical specialty)
The pneumonia of COVID-19 illness has often a subtle initial presentation making mandatory the use of biomarkers for evaluation of severity and prediction of final patient disposition. We evaluated the use of hydrogen sulfide (H2S) for the outcome of COVID-19 pneumonia.